Immunoaffinity capillary electrophoresis applications of clinical and pharmaceutical relevance
Immunoaffinity capillary electrophoresis applications of clinical and pharmaceutical relevance
复制标题
DOI:
10.1007/s00216-003-2326-y
复制
发表时间:
2004-01-01
影响因子:
4.3
通讯作者:
Guzman, NA
中科院分区:
文献类型:
--
作者:
Guzman, NA
In the last decade, several CE methods have replaced a number of traditional procedures in the clinical laboratory, in particular the identification and quantification of serum proteins, many substances of forensic relevance, and analytes characterized by specialized molecular diagnostic tests [1, 2, 3, 4, 5, 6, 7, 8]. Every mode of CE has been used successfully to generate a large number of clinical and pharmaceutical applications. However, recently a fully automated, two-dimensional CE approach that provides improved separation and sensitivity has begun to generate interest. One approach is to label proteins with a fluorogenic reagent, and separate the components using two capillaries, one with a separation buffer at neutral pH, the other with a separation buffer at high pH [12]. The other concept, termed immunoaffinity capillary electrophoresis (IACE) is gaining popularity in several laboratories. This concept of on-line preconcentration CE has been used as a promising technique to trap, enrich, clean, and analyze a variety of substances present in a cell, organelle, tissue, and/or biological fluid [11, 13, 14, 15]. A two-dimensional separation method, coupling immunoaffinity to CE for the immunoadsorption and separation of a selective immunoreactive substance (s)[11, 13, 14, 15] can be compared to the isolation of a needle from a haystack using a powerful magnet. Antibodies are biological “magnets” that are being used as powerful tools to provide synergy between immunoassay and CE for the development of pharmaceutical, forensic, and clinical applications. The description of an instrument that provides a multistep separation and assay of peptides and drugs has been reported [16]. The instrument contains one or a series of solid-phase, microextraction devices fabricated for use in on-line, affinity capillary electrophoresis. Each device, designed in a cross-shaped or cruciform configuration with four ports, includes a large-bore tube to transport samples and washing buffers, and a small-bore fused-silica capillary for separation of analytes. At the intersection of the transport and separation tubes, a small cavity was fabricated, termed the analyte concentrator-microreactor, which contains four porous walls or semipermeable membranes (one for each inlet and outlet of the tubes), permitting the confinement of beads or suitable microstructures within a restricted area. The surface of the beads in the analyte concentrators carried a molecular recognition adsorbing chemical or affinity ligand material (eg, antibody, lectin, enzyme, etc.). The role of this adsorbed stationary solid-phase (s) was to capture a target analyte present in a simple or complex matrix that has a selective high affinity for the bound material. Once the desired analyte is retained by the bound affinity ligand, salts and other unwanted or contaminating materials are washed away from the transport capillary with an appropriate buffer, leaving the target analyte noncovalently bound to the immobilized affinity ligand. Finally, each capillary is conditioned using an optimum separation buffer. Then, the target ligand is eluted with a small plug of a desorption buffer, usually 300 mM glycine buffer pH 3.4 or a neutral pH buffer containing organic solvent. Capillary electrophoresis is then performed for the eluted compound (s) within the separation capillary in a sequential mode, one capillary at the time. The separated compound (s) were monitored using one or an array of detectors, including a mass spectrometer, while exiting the capillary. Immunoaffinity capillary electrophoresis (IACE) performed with an instrument with multiple capillaries, each connected to an analyte concentrator within a device with a …